BioSyntech, Inc.

BSYI · OTC
Analyze with AI
12/31/2009
9/30/2009
6/30/2009
3/31/2009
Operating Activities
Net Income-$3,380-$3,624-$2,660-$3,070
Dep. & Amort.$88$92$100$94
Deferred Tax$0$0$0$0
Stock-Based Comp.-$3$111$189$0
Change in WC-$24$110-$694-$1,150
Other Non-Cash$1,763$1,300$1,152$1,757
Operating Cash Flow-$1,556-$2,011-$1,912-$2,370
Investing Activities
PP&E Inv.-$7$0$0$36
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$7$0$0$36
Financing Activities
Debt Repay.$2,942$1,242-$158-$158
Stock Issued$2$0$2$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$650-$213-$54$0
Financing Cash Flow$2,294$1,028-$211-$158
Forex Effect$10-$1-$0$2
Net Chg. in Cash$742-$984-$2,123-$2,491
Supplemental Information
Beg. Cash$696$1,680$3,803$6,294
End Cash$1,438$696$1,680$3,803
Free Cash Flow-$1,562-$2,011-$1,912-$2,335
BioSyntech, Inc. (BSYI) Financial Statements & Key Stats | AlphaPilot